New results from the phase 1 clinical trial, now published in the journal Nature, show that the therapeutic cancer vaccine activated tumor-specific immune cells that persisted in the body up to nearly ...

Since most studies on the NR have been performed with cell cultures, we present additional proof for the existence of these structures in vivo, focusing on a variety of differentiated cardiovascular ...

Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer Twenty-eight patients underwent apheresis and received CAR T cells. Sixteen and 12 patients ...

In addition, we will explore past and ongoing efforts along with achievements in the development of robust and promising microorganisms as cell factories to produce biologically active molecules.

Center for Renewable Energy and Storage Technologies (CREST), Thuwal 23955-6900, Kingdom of Saudi Arabia Materials Science and Engineering, Physical Science and Engineering Division, King Abdullah ...

Results The cell atlas unveiled an altered immune landscape across different pathological states of gallbladder diseases. GBC featured a more suppressive immune microenvironment with distinct T-cell ...

General Motors Research and Development, Warren, Michigan 48090, United States ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.